How Vaccines Work
Vaccines play an important role in keeping us healthy, by reducing the risk of infection. Read more on understanding vaccines and how they work.
Read More
Migraines: The Lowdown
Nothing ruins a perfectly good workday quite like a migraine. A migraine might be mild enough to where it might make work a little more challenging, or it might be severe that you cannot work at all. If you suffer from migraines, it is important to know what your triggers are and to plan out how to manage them at work.
Read More
The Coronavirus: Why Research is Important
A novel coronavirus (2019-nCoV) has been featured on every headline this past week as the WHO declares the outbreak a global public-health emergency. The 2019-nCoV causes illness ranging from the common cold to mores severe diseases such as Severe Acute Respiratory Syndrome (SARS), which can spread from person-to-person. The CDC believes that symptoms may appear […]
Read More
HPV
HPV or Human Papillomavirus Infection is the most common sexually transmitted infection in the United States, according to the CDC. Currently, there is no cure for HPV. Rochester Clinical Research is currently conducting a research study with the FDA approved vaccine Gardasil. This study will help prove that Gardasil not only prevents genital warts and cervical cancer, but also head and neck cancers caused by the same HPV virus.
Read More
Chikungunya: A Mosquito Spread Disease
Did you know mosquitoes can transmit diseases like malaria, dengue, West Nile virus, and chikungunya? Rochester Clinical Research is currently on the forefront of developing one of the first chikungunya vaccines this winter.
Read More
Rochester is at the forefront of developing new E. coli vaccine
Rochester is at the forefront of developing new E. coli vaccine
Antibiotic-Resistant Strains Posing Life-Threatening E. Coli Infections. This vaccine may cover several of those strains.
Read More
Ebola Vaccine Now Used in Africa
Rochester Clinical Research conducted an Ebola Vaccine Research study that is currently being used in Africa. It has been 99% effective for those who have gotten the vaccine.
Read More
Can a Single Pill Keep you Healthy to 100? A Clinical Trial at RCR Will Soon Find Out.
Rochester Clinical Research is proud to be a part of the cutting-edge research for the investigational drug RTB101, developed by resTORbio. The drug is aimed to arrest aging at a cellular level and has been studied for the past 15 years. This could lead not to a longer life, but a better life. RCR will be enrolling for a study with the RTB101 drug this fall 2019. For those interested in participating, we invite you to call us at 585-288-0890 or click the link to learn more.
Read MoreSmallpox Vaccine Needed for Risk of Bioterrorism
Routine vaccinations for smallpox ended 40 years ago after the World Health Organization officially declared global eradication of smallpox. This means the majority of the population is not protected. The threat of bioterrorism and natural re-emergence has prompted the US and countries around the world to prepare an updated vaccine which is more effective and easier to store. RCR is currently on the forefront of developing this vaccine.
Read More
RCR’s State of the Union Address: Coat of Arms
Each year, Rochester Clinical Research hosts a State of the Union address in March for all of the employees. The meeting recaps the year and looks to future plans that align with our mission – to excel in our field by providing quality care for study volunteers, quality data for sponsors and a quality team-oriented […]
Read More